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Abstract
Acupuncture has been commonly used as an adju-
vant therapy or monotherapy in the treatment of
Parkinson's disease in China and in other countries.
Animal studies have consistently show that this
treatment is both neuroprotective, protecting do-
paminergic neurons from degeneration and also re-
storative, restoring tyrosine hydroxylase positive
dopaminergic terminals in striatum, resulting in im-
provements in motor performance in animal mod-
els of Parkinsonism. Studies show that this protec-
tion is mediated through the same common mech-
anisms as other neuroprotective agents, including
anti-oxidative stress, anti-inflammatory and an-
ti-apoptotic pathways at molecular and cellular lev-
els. Restoration of function seems to involve activa-
tion of certain compensatory brain regions as a
mechanism at the network level to correct the im-
balances to the nervous system resulting from loss
of dopaminergic neurons in substantia nigra. Clini-
cal studies in China and Korea, in particular, have
shown a positive benefit of acupuncture in treating
Parkinson's disease, especially in reducing the dos-
es of dopaminergic medications and the associated
side effects. However, large and well-controlled clin-
ical trials are still needed to further demonstrate
the efficacy and effectiveness of acupuncture in
the treatment of Parkinson's disease.
© 2015 JTCM. All rights reserved.
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The use of acupuncture for treating different illnesses
originated in China about three thousand years ago, as
an important part of Traditional Chinese Medicine.
The treatment of Parkinson's tremor with acupuncture
and herbal medicine has a long history under the cate-
gory of "trembling" and "convulsive" disease. Acupunc-
ture treatment not only treats the brain where the dopa-
minergic neurons have been lost, which is the hallmark
of Parkinson's disease (PD), but also benefits the other
organ systems of Traditional Chinese Medicine, and is
therefore, also helpful for coping with non-motor relat-
ed symptoms and overall quality of life in PD patients.
This review summarizes the current understanding of
how acupuncture works in treating PD, based on infor-
mation obtained from preclinical and clinical trial stud-
ies, and functional network studies in humans.
INTRODUCTIONTO ACUPUNCTURE
AND ITS USE INTHETREATMENT OF
PD
Acupuncture is the primary therapy of Chinese medi-
cine, as described in Huang Di Nei Jing in the first cen-
tury BC.1,2 Acupuncture is very much respected in Chi-
na, so much so that its use was approved even during
the Chinese culture revolution.3 Classical acupuncture
is based on 14 mapped main channels on the body
with about 365 acu-points distributed on the channels
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(meridian system); the flow of Qi (the vital life force or
some kind of "energy") maintains the balance and har-
mony of Yin and Yang. Any blockage of these channels
or abnormal movement of Qi will result in illness, and
acupuncture by stimulating these acupoints along the
meridian channels with needles helps to restore move-
ment of the Qi and Qi homeostasis (De Qi) , thus
modulating the autonomic nervous system and reliev-
ing the symptoms of various illnesses.4,5 Acupuncture is
especially known for its effectiveness in reducing pain
such as dental and back pain due to triggering release
of analgesic neuropeptides.1,6,7 Acupuncture is delivered
by manual insertion of a needle or an additional ma-
neuver through twisting of the needles periodically. In
addition, the needles can serve as electrodes to deliver a
current stimulation with certain frequency (electroacu-
puncture, EA).8 For example, in rodents studies, 100 Hz
is considered the most effective frequency to achieve a
beneficial effect by acupuncture.9,10
The substrate for the meridian channels have been un-
der intense investigation. For example, connective tis-
sues or perivascular space with decreased electrical im-
pedance and increased electrical conductivity have
been suggested to constitute the meridian channels
with acupoints along the pathway.4,11 In addition, the
brain regions responsible for acupoint and triggered ac-
tivity in central nervous system are identified as extend-
ing from the dorsomedial prefrontal cortex, medial
mesencephalic reticular formation and brainstem net-
work through the medial thalamus and the hypothala-
mus and lateral habenular nucleus, medulla oblongata
and ventrolateral periaqueductal gray.3,5,8 Interestingly,
the habenula is suggested to be an anatomical substrate
for the control of depression in a PD model,12 and re-
lief from depression is one of neuropsychiatric benefits
resulting from acupuncture treatment of PD. Function-
al MRI (fMRI) studies suggest additional involvement
of posterior medial cortex and temporal cortex in the
central effect of acupuncture, named the "lim-
bic-paralimbic-neocortical network".13 For example,
acupuncture modulates the fMRI BOLD signal in ar-
eas associated with pain (anterior cingulate cortex and
periaquaductal gray), emotion (the amygdala), andmem-
ory (hippocampal formation and middle temporal gy-
rus).13,14 These areas are thought to be activated in acu-
puncture which disrupts the pathophysiological neuro-
nal networks and therefore relieves the symptoms by re-
placing themwith "therapeutic" network activation.15
PD is the second largest neurological disorder next to
Alzhermer's disease. With L-dopa medication treat-
ment, patients often develop involuntary motor move-
ments called L-dopa-induced dyskinesia after 5-10
years of use.16-18 When conventional treatment with
medication is not satisfactory, patients often resort to
complementary alternative medicine such as acupunc-
ture in hope of getting symptomatic improvement
without having disruptive side effects of pharmacother-
apy.19
In practice, complementary alternative medicine
(CAM) with acupuncture as the key component is
widely used world-wide in treating PD.19-25 At least
61% of PD patients in East Asia (Singapore) and 50%
of Latin-America (Argentina) and 1/3 in Sweden use at
least one type of CAM treating PD symptoms, with
acupuncture treating tremor in PD predominantly.20-22
A study in America shows that 40% of PD patients use
at least one type of CAM for treatment,23 similar to the
United Kingdom;24 the number of CAM users has
been increasing every year.19,25 In particular, with the
coverage of acupuncture by health insurance, acupunc-
ture users could be expected to further increase.1,22
CLINICAL STUDIES OF
ACUPUNCTURE INTREATING PD
Just like the higher use of CAM in Asia, the evaluation
of CAM tends to be more positive in Asia and for-
eign-language journals, for example, China, compared
to well-known journals.22,26,27 Acupuncture has been
used in Eastern Asia to treat PD under the category of
"trembling" and "convulsive disease" long ago, in par-
ticular for the control of tremor and pain, along with
herbal medicine.28-30 In China, clinical studies show
that acupuncture can help improve both motor symp-
toms and non-motor symptoms such as insomnia, de-
pression, constipation and overall life quality for PD
patients, and additionally, the dose of medication and
its side effect are reduced.31-35 Consistently, Korean stud-
ies show that acupuncture improves unified PD rating
score (UPDRS) and adjuvant therapy combined with
medication helps to reduce the doses and side ef-
fects.36-38 Reviews of Chinese clinical trials, with me-
ta-analysis on selected trials (meeting inclusion criteria)
suggest that the effectiveness of scalp acupuncture (a
type of acupuncture, in which needles are placed on
the head) treatment for PD is promising and a larger
well controlled trial is needed to confirm the efficacy of
scalp acupuncture.39
Acupuncture conducted in western countries has over-
all promising results, but they are not conclusive in par-
ticular for the motor rating score. For example, a practi-
tioner's notes showed that acupuncture at different lo-
cations in the body for a PD patient with 25 treat-
ments for 2-3 months helped to remove or reduced the
pain / muscle rigidity, tremor and depression.40 This
treatment works well for the early treatment when PD
is first manifested40 and also for a patient who had PD
for 12 years.41 Pilot studies with PD patients compar-
ing before and after treatment in USA show that acu-
puncture is safe and well-tolerated,42,43 significantly im-
proves sleep and rest in PD patients and the majority
of patients reported subjective improvement in hand-
writing, depression, tremor and slowness.42,43 With a
quite different acupuncture point placement, another
clinical trial in USA showed that there is a trend of im-
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provement in the motor subscale of UPDRS activities
of daily living for stage Ⅱ or Ⅲ PD.44 The motor sub-
scale of UPDRS showed inconsistent findings ranging
from no significant change,42 a trend of improvement44
or worsening score.43
The different and discrepant findings among the clini-
cal trials may be due to the different treatment plan (e.
g. locations of the needle, manual vs electro-acupunc-
ture, duration of the treatment and number of treat-
ment sessions) and the rigor of the methodological and
analytical approaches (such as the timing of efficacy as-
sessment after acupuncture to evaluate short vs
long-lasting effects, and double-blind vs open label tri-
als) and the appropriateness of the design of control
arm/group (e.g. eliminating potential placebo effect
and bias) and sample size.37,43 Perhaps a standard proto-
col should be established before the start of clinical tri-
als of the acupuncture efficacy in treating PD.
NEUROPROTECTIVE ROLE OF
ACUPUNCTURE IN ANIMALMODELS
OF PD AND ITS UNDERLYING
MECHANISMS
Animals studies using PD models [with 6-hydroxydo-
pamine (6-OHDA) and 1-methyl-4-phenyl-1,2,3,6-tet-
rahydropyridine (MPTP) injection] confirmed that
electro-acupuncture at various points or a combination
of acupoints [e.g. Duzhui (GV 14) / Baihui (GV 21),
Yanglingquan (GB 34) / Xuanzhong (GB 39), Ta-
ichong (LR 3), Duzhui (GV 14) / Fengfu (GV 16) /
Baihui (GV 20) , Zusanli (ST 36), Shanyijiao (SP 6)]
improves motor performance (reducing ipsilateral turn-
ing, its duration and the initiation time for turning,
rod performance) and provides neuroprotection of do-
paminergic neurons of the substantia nigra (pars com-
pacta) by significantly increasing the number of TH
positive neurons and dopaminergic projection termi-
nals in striatum.9,47-58 Yanglingquan (GB 34) and Zusan-
li (ST 36) are the most commonly used and effective
points, and located at the back of the knee and under
the knee joint (lateral to the tibia), respectively. Addi-
tionally, striatal dopamine content might increase in
the acupuncture group in PD mice compared to PD
mice without acupuncture but does not get back to the
original level;50,56 or did not increase significantly, sug-
gesting that the enhancement of motor performance is
not necessarily through increase of striatal dopamine
content.57,59,60
Pre- and post-synaptic modulation in basal ganglia
circuit following acupuncture contributing to
enhanced motor performance
In vivo microdialysis shows that acupuncture at Yan-
glingquan (GB 34) increases dopamine availability (via
increasing dopamine turnover ratios) in the striatum
and dopamine release in MPTP lesioned mice.61 Sin-
gle-photon emission computed tomography (SPECT),
a measure of cerebral blood flow and western blots
show increased dopamine uptake and dopamine trans-
porter (DAT) expression in the striatum and substantia
nigra after EA treatment.55 Post-synaptically, acupunc-
ture corrects the post-synaptic changes in PD mice by
restoring and reducing up-regulated phosphorylation
of DARP-32,61,62 FosB61 and D2 receptor.58 Additionally,
in the basal ganglia circuit, dynorphin expressing stria-
tonigral projection represents the direct pathway where-
as enkephalin-containing striatopallidal projection rep-
resents the indirect pathway.17,18 These two pathways
have to be in balance in order to have smooth motor
movement. This balance is interrupted in PD and relat-
ed L-dopa-induced dyskinesia,17 and electroacupunc-
ture can restore the homeostasis of the output of GA-
BA ergic neurons. For example, acupuncture can re-
store down-regulated substance P neuropepetide and
up-regulated GAD 67 (GABA synthesizing enzyme)
mRNA,51 and reduces GABA content in the midbrain
(SNr) and cortex, increases GABA content in the stria-
tum and cerebellum, and ultimately ameliorates motor
abnormality in hemiparkinsonian rats (with medial
forebrain bundle transection or 6-OHDA lesion).51, 63
The above pre- and post-synaptic mechanisms and ho-
meostasis of direct- and indirect-pathways of the basal
ganglia circuit may contribute to the therapeutic bene-
fit of electro-acupuncture in PD models and patients.58
Molecular and cellular mechanism underlying the
role of acupuncture in neuroprotection in PD models
Lack of neurotrophic factors, apoptosis (programmed
cell death), inflammatory process and oxidative stress
have been implicated in pathogenesis of PD.45,46,64,65
Agents that provide the resources of neurotrophic fac-
tor (which supports neuronal function), are anti-apop-
totic, anti-inflammatory and/or anti-oxidative stress
and presumably protect neurons and their circuitry
from degeneration as a result of insult.45,66,67 Indeed,
neuroprotective processes are thought to underlie the
beneficial physiological changes following acupunc-
ture66,68 along with increase of proliferating stem cells in
the subventricular zone.69 Peptide finger printing MS
identified nine proteins involved in cell death regula-
tion, inflammation or restoration from damage and
neuroprotection such as cyclophilin A.66,68 Consistently,
microarray analysis of the gene expression profile has
shown that pathological changes in genes involving cy-
tokine-mediated apoptosis, inflammation and oxida-
tive stress are corrected by acupuncture in PD models.64
First, with regard to neurotrophic factors, 100 Hz elec-
tric acupuncture [at Taodao (Du 13) and Baihui (GV
21), or Baihui (GV 20) - Taiyang (EX-HN5)] increases
the expression level of BDNF mRNA and GDNF
mRNA at SNc and ventral tegmental area, and GDNF
receptor at SN and striatum, and prevents degenera-
tion of dopaminergic neurons in PD rats.9,10,70,71 Sec-
ond, apoptosis-triggered cell death is reduced by elec-
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tro-acupuncture [at Taichong (LR 3) and Fengfu (GV
16) or Yanglingquan (GB 34)] on day 7 after 6-OH-
DA lesioning in PD rats.49,53,65 For example, Ubiqui-
tin-conjugating enzyme E2N suggested to be involved
in cell death regulation is normalized by electro-acu-
puncture.68 Acupuncture also corrects the down-regulat-
ed pathways regulating cytokin-cytokin receptor inter-
action and genes (such as deoxyribonuclease 1-like 2)
involved in programmed cell death.64,65 Third, acupunc-
ture reduces inflammatory processes in PD rodents at
acupoint Duzhui (GV 14) / Baihui (GV 21), Yan-
glingquan (GB 34) and Taichong (LR 3).50,66,68,72 For ex-
ample, lesion induced microglia activation, macro-
phage antigen complex-1 (MAC-1, a marker of microg-
lia activation), cyclooxygenase-1 (COX-2) and induc-
ible nitric oxide synthase (iNOS) and TNF-α and in-
terleukin (IL)-1b mRNA are reduced by acupuncture
in MFB-transected rats and MPTP lesioned mice.50,72
Peptide finger printing MS suggests that inflammatory
proteins, for example, CLP-coactosin-like protein, is
normalized by daily acupuncture treatment 2 h after
MPTP lesion for 7 days.68 Gene array analysis con-
firmed that one of the 5 genes, DUSPs (dual specificity
phosphatases 4) involved in pathogen-mediated immu-
nity, down-regulated in MPTP mice, were exclusively
upregulated by acupuncture [at Yanglingquan (GB 34)
and Taichong (LR 3)] 2 h after MPTP injection in
mice (every 2 days for 14 sessions) in the thalamic re-
gion (an area damaged in PD).65
Lastly, on anti-oxidative stress, relatively recent find-
ings show that acupuncture reduces oxidative stress in
toxin-lesioned PD rodent models,52,56,64-66,73 likely
through interactions with intracellular signaling path-
ways such as PI3K/Akt pathway.61 Acupuncture at Yan-
glingquan (GB 34) / Xuanzhong (GB 39) normalizes
proteins that are changed in MPTP mice, including cy-
tosolic malate dehydrogenase, Munc18-1, hydroxyacyl
glutathione hydrolase and cytochrome c oxidase in-
volved in cellular mechanism, which restore TH neu-
rons and terminals in SN and striatum possibly
through reducing oxidative stress and increasing antiox-
idant enzyme activity.73 Indeed, studies have provided
evidence that acupuncture reduces oxidative stress and
free radical formation.52,56 Antioxidative parameters (in-
cluding superoxide dismutase, glutathione peroxidase)
are decreased and malodialdehyde (MDA)/H2O2 is in-
creased in neurotoxin lesioned rats, and EA at com-
pound acupoints [Yanglingquan (GB 34), Taichong
(LR 3), and/or Zusanli (ST 36) and Sanyinjiao (SP 6) /
Xuehai (10)], applied the same day of 6-OHDA lesion-
ing or the next day following MPTP lesioning, reverses
the changes, increases glutathione concentration and
improves PD motor function (reducing apomorphine-
induced rotation).52,56 GeneChip gene array analysis of
thalamic genes expression showed that the DUSPs
genes that are involved in regulating the oxida-
tive-stress-activated c-Jun N-terminal kinases (JNKs)
(down-regulated in MPTP-lesioned mice) are upregu-
lated by acupuncture stimulation, and the gene un-
coupling protein 2 that are involved in oxidative
damage by ROS (up-regulated in MPTP mice) is
down-regulated by acupuncture at Yanglingquan (GB
34) and Taichong (LR 3).65 Similarly, in striatum,
genechip microarray analysis and real-time RT-PCR
showed that acupuncture stimulation of chronic
MPTP mice model (2 h after the first MPTP injec-
tion) at acupoints Yanglingquan (GB 34) and Ta-
ichong (LR 3) upregulates genes encoding chaperon
protein, neuroglobin and neurotrophin, proteins and
pathways involved in mitogen-activated protein ki-
nase (MAPK) signaling pathway, suggesting that acu-
puncture promotes genes and pathways that facilitate
neural survival and reduce oxidative stress. On the
other hand, acupuncture down- regulates genes such
as gap junction protein, tubulin and insulin-like
growth factor and pathways involved in cell commu-
nication and gap junction, suggesting that acupunc-
ture disinhibits genes and pathways that promote
neural regeneration.54 Additionally, acupuncture, act-
ing as anti-oxidant agent, reduces Fe3+ level, the level
of which in SN being suggested to contribute to the
DA neurons' degeneration.66
Network mechanism underlying acupuncture effect
based on imaging studies from the perspective of
thalamus connectivity
At the brain circuitry level, Fairgold15 hypothesized
that EA modulates excitatory and inhibitory networks,
and results in network plasticity (mediated by the
above discussed neurotropic and other factors). This
modified network disrupts the dysfunctional network
(consisting of the same conditional multi-receptive neu-
rons in specific brain areas) and reduces the symptoms.
This hypothesis might help partially explain how acu-
puncture mediates effects in PD patients. In PD pa-
tients, the substantia nigra, caudate/putamen, thala-
mus, are parts of the basal ganglia circuit and its func-
tional connectivity is impaired; 74,75 acupuncture stimu-
lation activates these regions which is evidenced in the
increased BOLD signal (index of brain activation)
based on fMRI studies and placebo-controlled experi-
ments.65,76 This activation of basal ganglia-thalamocorti-
cal circuit following acupuncture, correlates with im-
provement of finger tapping in patients with early
stage of PD.76 Positron emission tomography (measure
of cerebral metabolism) and SPECT studies in patients
also support the activation of this modified network by
acupuncture (with medication) in the parietal and oc-
cipital lobes, frontal lobes, basal ganglia and cerebel-
lum in the affected hemisphere of the patients, com-
pared to medication only group.77,78 The most recent
fMRI study in a dog model of PD characterized the dif-
ferential pathway activation of normal, PD versus acu-
puncture treating PD conditions during a passive
movement task.39 Neural dopaminergic pathway includ-
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ing the basal nuclei, thalamus and limbic system is de-
activated in a dog model of PD and experiences similarly
reduced fMRI BOLD signal in the limbic and paralim-
bic regions in telecephalon, diencephalon, brain stem
and cerebellum in normal individual.79 Following acu-
puncture treatment [at Zusanli (ST 36)], BOLD sig-
nals of these areas are enhanced in the non-lesioned
motor-sensory areas, bilateral parietal lobes, thalamus,
limbic system and the cerebellar vermis.39
The thalamus, a structure originally thought to be a
passive relay of sensory information, along with cere-
bellum (a structure thought to be involved in motor
movement and balance), play an important role in
the striato-thalamo-cortical and cerebello-thalamo-cor-
tical pathways. Damage of these pathways may result
in akinesia with rigidity and tremor, along with
non-motor symptoms.80-84 Thalamic nuclei are activat-
ed during fMRI following acupuncture in PD, as
shown above. The major motor nuclei of the thala-
mus, the ventral anterior (VA) / ventral lateral (VL)
and MD nuclei are robustly connected with the fron-
tal cortex especially the anterior cingulate and dorso-
lateral prefrontal areas, and basal ganglia structures
[SNr and globus pallidus internus (GPi)], and there-
fore, have a key role for initiation of motor move-
ment, cognition and emotions.85,86 Indeed, functional
studies show that disruption of these connections is
manifested in PD at resting state, which may explain
why PD patients have difficulty to initiate motor
movement.75 In addition, the ventral thalamus (intri-
cately connected with the SNr and GPi and cerebel-
lum) have clusters of tremor generation sites in PD,80,83
as supported by the evidence that its increased gray
matter density (in the posterior thalamic VL nucleus)
correlates with resting tremor amplitude in unilateral
Parkinsonian tremor.87 This may help explain why
clinical trials show effectiveness of acupuncture in
controlling tremor symptoms after modulation of
tremor generation sites in the ventral thalamus by
acupuncture and how deep brain stimulation of ad-
vanced PD at thalamic nuclei are used in controlling
tremor and reducing L-dopa induced dyskinesia.88,89
Moreover, the thalamic MD nucleus and its connec-
tion with the prefrontal cortex are suggested to be in-
volved in non-motor symptoms, including depression
and apathy in PD.90-92 Thalamic damage, including re-
duction of gray matter and white matter of frontal cor-
tex and cingulate cortex, are correlated with depression
and apathy in PD.91,92 Thalamo-cortical projections to
the superficial layers of the cortex, represented by calbi-
ndin-positive widespread projection system, underlie
the sleep-wake cycle and consciousness.86,93 This diffuse
projection system may be altered by acupuncture and
promote sleep and rest (as shown in the clinical trial
above).
Finally, the anterior thalamic nuclei, which are promi-
nent in primates compared to rodents, play a central
role in the Papez's circuit for emotion and are robustly
connected with medial and orbital prefrontal cortex.85,94,95
This emotional circuitry might influence the expectan-
cy and perception of pain upon acupuncture and un-
derlie the analgesic effect of acupuncture.96 The func-
tion of the individual thalamic nuclei such as the ante-
rior thalamic nuclei underlying acupuncture effect in
treating PD needs to be clarified.
The above supports clinical evidence of acupuncture to
help improve depression, a major neuropsychiatric
symptom in PD, and overall life quality through the
compensatory activation of thalamic nuclei.65 The criti-
cal role of the thalamus is also appreciated by evidence
from microarray studies of molecule candidates isolat-
ed from the thalamus, the expression of which are sig-
nificantly increased or reduced in Parkinsonian models
following acupuncture.65
SUMMARY AND FUTURE STUDIES
Acupuncture has been a popular choice as alternative
medicine in USA and Western Medicine for treating
difficult cases, pain and cancer patients etc.19 Studies
at the cellular, molecular and circuitry level with ani-
mal models of PD and human trials suggest the fol-
lowing mechanisms. First, acupuncture, just like oth-
er neuroprotective agents, is anti-inflammatory, an-
ti-oxidative stress, anti-apoptotic and neurotrophic,
increases dopamine availability, restores post-synaptic
changes due to the dopamine loss through changes
in certain gene and protein expression. Second, at
the circuitry level in the central nervous system and
even organ systems, acupuncture re-activates the dys-
functional brain circuitry for motor and non-motor
function and relieves the symptoms. Clinical trials
suggest that acupuncture is effective in non-motor
symptoms in sleep, rest and depression. A clear bene-
fit is that acupuncture can reduce the therapeutic
L-dopa treatment dose and its related side effect,
L-dopa-induced dyskinesia. Acupuncture, as potential
neuroprotective agent, is supported by preclinical ani-
mal studies with consistent efficacy and pilot clinical
trials with positive evidence of acupuncture's benefit
in treating PD (and it is safe and well tolerated). A
well designed clinical trial to test acupuncture as neu-
roprotective agent is warranted.97 For example, acu-
puncture's real effect in treating PD, especially in im-
proving Unified Parinson's Disease Rating Scale, still
waits to be studied in double-blind, randomized, pla-
cebo-controlled well-designed trials (considering trial
sample size, acupoint selection and treatment proto-
col etc.). The research or clinical questions should be
clear, which will help design well-controlled studies.
Perhaps, an early use of acupuncture is the potential
to improve PD symptoms. Finally, a future question
that needs to be explored is whether acupuncture can
slow down the disease progression or facilitate neuro-
nal regeneration.
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